Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy | HTML | Acta Dermato-Venereologica
PHARMACY POLICY STATEMENT
Phototherapy remains a valuable psoriasis treatment
![PDF] Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5bf0a699fddfc4f70f2e2049b59250c0f12b4210/2-Figure1-1.png "PDF] Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? | Semantic Scholar")
PDF] Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox? | Semantic Scholar
AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments - iData Research
Full article: Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease
Frontiers | Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Early administration of adalimumab for paediatric uveitis due to Behçet's disease | Pediatric Rheumatology | Full Text
View Image
An extraordinary form of the Melkersson-Rosenthal syndrome successfully treated with the tumour necrosis factor-α blocker adalimumab | BMJ Case Reports
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial - The Lancet
The best combination for the treatment of Hidradenitis Suppurativa - Dr. Anuj Pall MD, PhD - YouTube
Treatment of Recalcitrant Generalized Granuloma Annulare With Adalimumab - JDDonline - Journal of Drugs in Dermatology
HUMIRA (adalimumab) Hidradenitis Suppurativa Clinical Data
Extensive Nevus Comedonicus with Inflammatory Nodules and Cysts Controlled with Adalimumab
Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa* - Cao - 2021 - British Journal of Dermatology - Wiley Online Library
Excimer Laser Therapy for Hairline Psoriasis: A Useful Addition to the Scalp Psoriasis Treatment Algorithm
Excimer Laser Therapy for Hairline Psoriasis: A Useful Addition to the Scalp Psoriasis Treatment Algorithm
Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966 | Scientific Reports
Protect at all costs: How the maker of the world's bestselling drug keeps prices sky-high | Fortune
TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis | Nature Communications
Adalimumab for Refractory Folliculitis Decalvans. — Donovan Hair Clinic
ESPRIT: 10-year post-marketing surveillance registry of adalimumab for moderate to severe psoriasis: All treatment-emergent mali
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial - The Lancet Rheumatology
Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
